PhD in Life Sciences

Department for BioMedical Research at the University of Bern and the University Clinic of Rheumatology and Immunology at Inselspital, Bern./nResearch focuses on design and development of therapeutic cancer vaccines based on virus-like nanoparticles for treatment of solid tumors in mouse models to provide proof-of-concept./nAim: develop novel therapeutic VLP-based cancer vaccines using AI-driven design approaches, with in vivo and in vitro experimentation and evaluation of immune responses (B-cell activation and complement involvement) in transgenic mouse models./nLocation: Bern, Switzerland./nStart of employment: April 1, 2026./nDuration: 3 years.